Human Immunology News Volume 11.11 | Mar 21 2023

    0
    55








    2023-03-21 | HIN 11.11


    Human Immunology News by STEMCELL Technologies
    Vol. 11.10 – 21 March, 2023
    TOP STORY

    Human T Cell Generation Is Restored in CD3δ Severe Combined Immunodeficiency through Adenine Base Editing

    Delivery of mRNA encoding a laboratory-evolved adenine base editing and guide RNA into a CD3δ severe combined immunodeficiency patient’s hematopoietic stem and progenitor cells resulted in a 71.2% ± 7.85% correction of the pathogenic mutation.
    [Cell]

    AbstractPress ReleaseGraphical Abstract
    PUBLICATIONSRanked by the impact factor of the journal

    Immune Landscape in Invasive Ductal and Lobular Breast Cancer Reveals a Divergent Macrophage-Driven Microenvironment

    To investigate the immunobiology of ER+ breast cancer in women with invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC), scientists performed phenotypic, transcriptional, and functional analyses for a cohort of treatment-naive IDC and ILC tumors.
    [Nature Cancer]

    AbstractPress Release

    Stepwise Activities of mSWI/SNF Family Chromatin Remodeling Complexes Direct T Cell Activation and Exhaustion

    Researchers comprehensively profiled the genomic occupancy of mSWI/SNF chromatin remodeling complexes throughout acute and chronic T cell stimulation.
    [Molecular Cell]

    Full ArticleGraphical Abstract

    Immune Subset-Committed Proliferating Cells Populate the Human Foetal Intestine throughout the Second Trimester of Gestation

    Investigators showed the immune subset composition of the human fetal intestine during development, by longitudinal spectral flow cytometry analysis of samples between 14 and 22 weeks of gestation.
    [Nature Communications]

    Full Article

    A Neomorphic Mutation in the Interferon Activation Domain of IRF4 Causes a Dominant Primary Immunodeficiency

    The authors reported on a heterozygous interferon regulatory factor 4 (IRF4) missense variant identified in three patients from a multigeneration family with hypogammaglobulinemia, characterizing the immunological consequences of this neomorphic mutation.
    [Journal Of Experimental Medicine]

    Full Article

    IFN-γ Signature Enables Selection of Neoadjuvant Treatment in Patients with Stage III Melanoma

    Patients with stage III melanoma and high intra-tumoral interferon-γ (IFN-γ) scores were randomized to neoadjuvant nivolumab or nivolumab + domatinostat, while patients with low IFN-γ scores received nivolumab + domatinostat or ipilimumab + nivolumab + domatinostat.
    [Journal Of Experimental Medicine]

    Full Article

    Pre-Existing Fc Profiles Shape the Evolution of Neutralizing Antibody Breadth following Influenza Vaccination

    Scientists applied a systems approach to profile hemagglutinin- and neuraminidase-specific humoral signatures that track with the evolution of broad immunity in a cohort of vaccinated individuals and validated these findings in a second longitudinal cohort.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    Combined Disruption of T Cell Inflammatory Regulators Regnase-1 and Roquin-1 Enhances Antitumor Activity of Engineered Human T Cells

    Researchers targeted a regulatory axis of T cell inflammatory responses, Regnase-1 and Roquin-1, to enhance antitumor responses in human T cells engineered with two clinical-stage immune receptors.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    Isoform-Specific Knockdown of Long and Intermediate Prolactin Receptors Interferes with Evolution of B-Cell Neoplasms

    In overt human B-cell malignancies, knockdown of the long plus intermediate isoforms of the PRL receptor (LF/IFPRLR) reduced B-cell viability and their MYC and BCL2 expression, and reduced the growth of human B-cell malignancies in vitro and in vivo.
    [Communications Biology]

    Full Article
    Share your feedback for the chance to win an Uber Eats gift card
    REVIEWS

    Clonal Hematopoiesis and Dysregulation of the Immune System

    Scientists review studies describing the connection between clonal hematopoiesis (CH) and pathological immune dysfunction, the effects of CH-associated genetic alterations on the function of myeloid and lymphoid cells, and the clinical and therapeutic implications of CH as a target for immunomodulation.
    [Nature Reviews Immunology]

    Full Article

    B Cells in the Tumor Microenvironment: Multi-Faceted Organizers, Regulators, and Effectors of Anti-Tumor Immunity

    The authors summarize our current understanding of tumor-infiltrating lymphocyte-B cells and plasma cells in human cancer, highlighting the compelling therapeutic opportunities offered by their unique tumor recognition and effector mechanisms.
    [Cancer Cell]

    Full Article
    INDUSTRY AND POLICY NEWS

    OncoC4 Bags $200 Million in CTLA-4 Antibody Pact with BioNTech

    BioNTech and OncoC4 are partnering up to develop and commercialize OncoC4’s anti-CTLA-4 monoclonal antibody candidate, ONC-392, as a monotherapy or combination therapy for various cancers.
    [Gene Online (OncoC4)]

    Press Release
    FEATURED EVENT

    From First Breath: Lung Development, Infection, Repair and Aging

    April 23 – 26, 2023
    Snowbird, Utah, United States

    > See All Events

    JOB OPPORTUNITIES

    Senior Scientist – Vaccine and Monoclonal Antibody Development

    Pfizer, Inc. – Any North American Pfizer Site

    Assistant/Associate Professor – Immunity and Inflammation

    Rutgers New Jersey Medical School – Newark, New Jersey, United States

    Postdoctoral Researcher – Immune Competent Tumor-on-Chip Model

    Oslo University Hospital – Oslo, Norway

    Postdoctoral Position – Immunology of Infection and Vaccination

    Umeå University – Umeå, Sweden

    Senior Scientist – Preclinical Immunotherapy of Cancer

    University Hospital Duesseldorf – Düsseldorf, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter